
Reset all filters
01 2Sunovion Pharmaceuticals Canada Inc. (as agent for Cubist Pharmaceuticals LLC)
Reset all filters
01 12344318
02 12743326
Reset all filters
01 2Daptomycin
Reset all filters
01 2Powder for solution
Reset all filters
01 12019-09-24
02 12021-01-18
Patent Expiration Date : 2019-09-24
Date Granted : 2006-07-04
Brand Name : CUBICIN
Patent Number : 2344318
Filing Date : 1999-09-24
Strength per Unit : 500mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2019-09-24
Date Granted : 2006-07-04
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2021-01-18
Date Granted : 2015-04-07
Brand Name : CUBICIN
Patent Number : 2743326
Filing Date : 2001-01-18
Strength per Unit : 500mg / vial
Dosage Form : Powder for solution
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2021-01-18
Date Granted : 2015-04-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF